Evidence of Repurposing Drugs and Identifying Contraindications from Real World Study in Parkinson’s Disease
Author:
Affiliation:
1. Department of Neurology and National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
Funder
Ministry of Science and Technology of the People's Republic of China
National Natural Science Foundation of China
Publisher
American Chemical Society (ACS)
Subject
Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00456
Reference69 articles.
1. The clinical utility of posturography
2. Drug repositioning: identifying and developing new uses for existing drugs
3. Measuring the Burden of Hospitalization in Patients with Parkinson´s Disease in Spain
4. The ongoing pursuit of neuroprotective therapies in Parkinson disease
5. Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using a smartphone-based self-management platform to study sex differences in Parkinson’s disease: multicenter, cross-sectional pilot study;BMC Medical Informatics and Decision Making;2024-06-21
2. The potential of innovative trial design for efficiently evaluating repurposed drugs;Nature Reviews Drug Discovery;2023-08-03
3. Heath management app use in Parkinson’s disease and quality of life during the COVID-19 pandemic;Communications Medicine;2023-02-11
4. Use of real‐world evidence in translational pharmacology research;Fundamental & Clinical Pharmacology;2021-11-02
5. Social listening – revealing Parkinson’s disease over day and night;BMC Neurology;2021-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3